Clinical Trial

A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

Name: A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis — clinical trial record (NCT07465289)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of the study is to assess the long-term safety and efficacy of rozanolixizumab in adult study participants with ocular myasthenia gravis.

Trial Details

NCT Number	NCT07465289
Lead Sponsor	UCB Biopharma SRL
Conditions	Ocular Myasthenia Gravis
Enrollment	100 participants
Start Date	2026-07-27
Primary Completion	2031-01-23 (estimated)
Study Completion	2031-01-23 (estimated)
Updated on ClinicalTrials.gov	2026-03-11